CDKN1C CDKN1C CDKN1C E2F1 TP53 TP53 TP53 TP53
ENST00000380725 ENST00000414822 ENST00000440480 ENST00000343380 ENST00000269305 ENST00000420246 ENST00000445888 ENST00000504937 (∆)
IDENTIFICATION 
CODE*
Age Tumor cells Characterization CDKN1C E2F1 TP53 CDKN1C-002 CDKN1C-001 CDKN1C-003 E2F1-001 TP53-001 TP53-005 TP53-002 TP53-008
554 Adult >80% Cortical / Common T-LBL -3,625 4,214 0,31 -2,80 -4,60 -1,81 1,31 1,28 0,16 0,28 0,74
238 Adult >80% PreT / Immature T-LBL -2,766 -0,761 0,536 -2,66 -4,30 -4,76 0,46 0,49 -0,73 -0,53 0,81
408 Adult >80% Cortical / Common T-LBL -2,795 -0,434 0,028 -3,53 -2,15 -4,42 0,05 0,46 -1,01 -0,47 -0,01
192 Adult 90% Cortical / Common T-LBL -5,38 1,769 -0,78 -2,82 -3,29 -4,32 1,46 -0,71 1,17 -1,33 2,65
346 Adult 95% Cortical / Common T-LBL -4,473 2,78 -0,184 -2,41 -25,99 -2,00 2,05 -9,74 0,21 -3,80 3,26
460 Pediatric 70% Cortical / Common T-LBL -3,522 0,933 -0,395 -1,13 -22,38 -1,50 1,10 -2,10 0,45 -0,57 2,41
840 Pediatric >80% ProT / Immature T-LBL -3,988 1,104 0,659 -3,52 -2,69 -4,43 1,66 1,32 0,97 0,52 1,26
521 Pediatric 90% Cortical / Common T-LBL -5,95 -4,12 -3,40 1,68 0,66 2,65 1,10 -0,05
829 Adult —  Immature T-LBL -3,023 -0,436 0,171
188 Adult — T-LBL -3,251 1,046 0,046
135 Adult — Medular / Common T-LBL -5,107 1,742 -0,295
080 Pediatric — Medular / Common T-LBL -3,21 0,029 -0,666
104 Pediatric — Cortical / Common T-LBL -4,975 1,015 1,773
038 Pediatric — T-LBL -0,682 1,257 0,522
101 Pediatric — T-LBL -3,736 1,704 -1,689
209 Pediatric — T-LBL -1,187 0,453 0,389
639 Pediatric 80% Medular / Common T-LBL -2,498 -0,479 0,07
001 Pediatric — ProT-PreT / Immature T-LBL -2,766 2,651 0,547
*Identification  of  the  biological  samples  of  the  Biobank  will  be  subjected  to  a  coding  process. Each  sample  is  assigned  an identification code. 
qrtRT-PCR
Ex
te
n
d
ed
 c
o
h
o
rt
Ex
p
lo
ra
to
ry
 c
o
h
o
rt
Supplementary Table 1. Characterization of the human sample collection in the exploratory cohort. Lymphomas were diagnosed (see Characterization column) according to World Health Organization Classification of Hematological Malignancies and recommendations from the European